{"id":17606,"date":"2021-11-16T14:24:41","date_gmt":"2021-11-16T21:24:41","guid":{"rendered":"https:\/\/fuentesfidedignas.com.mx\/?p=17606"},"modified":"2021-11-16T14:24:41","modified_gmt":"2021-11-16T21:24:41","slug":"pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu","status":"publish","type":"post","link":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/","title":{"rendered":"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU"},"content":{"rendered":"\n<p><strong><em>Pfizer afirm\u00f3 que complet\u00f3 la presentaci\u00f3n de su solicitud de autorizaci\u00f3n de uso de emergencia del f\u00e1rmaco, Paxlovid, ante la FDA.<\/em><\/strong><\/p>\n\n\n\n<p>Ciudad de M\u00e9xico.- Pfizer Inc dijo este martes que est\u00e1 solicitando la autorizaci\u00f3n en Estados Unidos para su p\u00edldora antiviral experimental contra el Covid-19, que redujo en un 89% la posibilidad de hospitalizaci\u00f3n o muerte de adultos con riesgo de enfermedad grave en una prueba cl\u00ednica.<\/p>\n\n\n\n<p>Pfizer afirm\u00f3 que complet\u00f3 la presentaci\u00f3n de su solicitud de autorizaci\u00f3n de uso de emergencia del f\u00e1rmaco, Paxlovid, a la Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en ingl\u00e9s), incluyendo datos de las pruebas cl\u00ednicas de la farmac\u00e9utica.<\/p>\n\n\n\n<p>El f\u00e1rmaco oral podr\u00eda ser una nueva y prometedora arma en la lucha contra la pandemia, ya que puede tomarse como tratamiento temprano en casa para ayudar a prevenir las hospitalizaciones y las muertes por Covid-19.<\/p>\n\n\n\n<p>Adem\u00e1s, podr\u00eda convertirse en una herramienta importante en pa\u00edses y zonas con acceso limitado a las vacunas o con bajas tasas de vacunaci\u00f3n.<\/p>\n\n\n\n<p>No est\u00e1 claro cu\u00e1ndo se pronunciar\u00e1n los organismos reguladores estadounidenses sobre la solicitud de Pfizer.<\/p>\n\n\n\n<p>Merck &amp; Co Inc y Ridgeback Biotherapeutics, que est\u00e1n desarrollando una p\u00edldora competidora, el molnupiravir, completaron su presentaci\u00f3n para uso de emergencia el 11 de octubre.<\/p>\n\n\n\n<p>Un grupo de asesores externos de la FDA se reunir\u00e1 para estudiar la solicitud de Merck el 30 de noviembre, y se espera que el f\u00e1rmaco est\u00e9 disponible este a\u00f1o.<\/p>\n\n\n\n<p>\u201cNos estamos moviendo lo m\u00e1s r\u00e1pidamente posible en nuestro esfuerzo por poner este tratamiento potencial en manos de los pacientes, y esperamos trabajar con la FDA de Estados Unidos en su revisi\u00f3n de nuestra solicitud, junto con otras agencias reguladoras de todo el mundo\u201d, dijo el presidente ejecutivo de Pfizer, Albert Bourla, en un comunicado de prensa.<\/p>\n\n\n\n<p>El fabricante de medicamentos, que tiene su sede en Nueva York, se\u00f1al\u00f3 que ha iniciado el proceso de solicitud de autorizaci\u00f3n en varios pa\u00edses, entre ellos el Reino Unido, Australia, Nueva Zelanda y Corea del Sur, y tiene previsto presentar m\u00e1s solicitudes internacionales.<\/p>\n\n\n\n<p>Pfizer hab\u00eda dicho el martes que permitir\u00eda a los fabricantes de gen\u00e9ricos suministrar su p\u00edldora contra el Covid-19 en 95 pa\u00edses de ingresos bajos y medios mediante un acuerdo de licencia con el grupo internacional de salud p\u00fablica Medicines Patent Pool (MPP).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer afirm\u00f3 que complet\u00f3 la presentaci\u00f3n de su solicitud de autorizaci\u00f3n de uso de emergencia del f\u00e1rmaco, Paxlovid, ante la FDA. Ciudad de M\u00e9xico.- Pfizer Inc dijo este martes que est\u00e1 solicitando la autorizaci\u00f3n en Estados Unidos para su p\u00edldora antiviral experimental contra el Covid-19, que redujo en un 89% la posibilidad de hospitalizaci\u00f3n o [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":17607,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","footnotes":""},"categories":[39],"tags":[332,59,416,407],"class_list":{"0":"post-17606","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-noticias-nacionales","8":"tag-coronavirus","9":"tag-covid-19","10":"tag-sars-cov-2","11":"tag-vacuna-anticovid"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU - Fuentes Fidedignas<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU - Fuentes Fidedignas\" \/>\n<meta property=\"og:description\" content=\"Pfizer afirm\u00f3 que complet\u00f3 la presentaci\u00f3n de su solicitud de autorizaci\u00f3n de uso de emergencia del f\u00e1rmaco, Paxlovid, ante la FDA. Ciudad de M\u00e9xico.- Pfizer Inc dijo este martes que est\u00e1 solicitando la autorizaci\u00f3n en Estados Unidos para su p\u00edldora antiviral experimental contra el Covid-19, que redujo en un 89% la posibilidad de hospitalizaci\u00f3n o [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/\" \/>\n<meta property=\"og:site_name\" content=\"Fuentes Fidedignas\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Fuentes-Fidedignas-368234489921644\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-16T21:24:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/11\/PFIZER_001.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Reuters\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@fidedignas\" \/>\n<meta name=\"twitter:site\" content=\"@fidedignas\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reuters\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/\"},\"author\":{\"name\":\"Reuters\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#\\\/schema\\\/person\\\/699c239076aac7aa88ecc3c15c72710f\"},\"headline\":\"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU\",\"datePublished\":\"2021-11-16T21:24:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/\"},\"wordCount\":432,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PFIZER_001.jpg\",\"keywords\":[\"Coronavirus\",\"Covid-19\",\"SARS-CoV-2\",\"Vacuna anticovid\"],\"articleSection\":[\"NOTICIAS NACIONALES\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/\",\"url\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/\",\"name\":\"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU - Fuentes Fidedignas\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PFIZER_001.jpg\",\"datePublished\":\"2021-11-16T21:24:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PFIZER_001.jpg\",\"contentUrl\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PFIZER_001.jpg\",\"width\":640,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/2021\\\/11\\\/16\\\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#website\",\"url\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/\",\"name\":\"Fuentes Fidedignas\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#organization\",\"name\":\"Fuentes Fidedignas\",\"url\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/logo-retina.png\",\"contentUrl\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/logo-retina.png\",\"width\":280,\"height\":51,\"caption\":\"Fuentes Fidedignas\"},\"image\":{\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Fuentes-Fidedignas-368234489921644\",\"https:\\\/\\\/x.com\\\/fidedignas\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/#\\\/schema\\\/person\\\/699c239076aac7aa88ecc3c15c72710f\",\"name\":\"Reuters\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/06c46a9bb47e91c2e7c5aa85ad0855c43a11fd5a7b8dd6ec0e8fe8e471140a59?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/06c46a9bb47e91c2e7c5aa85ad0855c43a11fd5a7b8dd6ec0e8fe8e471140a59?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/06c46a9bb47e91c2e7c5aa85ad0855c43a11fd5a7b8dd6ec0e8fe8e471140a59?s=96&d=mm&r=g\",\"caption\":\"Reuters\"},\"url\":\"https:\\\/\\\/fuentesfidedignas.com.mx\\\/index.php\\\/author\\\/reuters\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU - Fuentes Fidedignas","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/","og_locale":"es_MX","og_type":"article","og_title":"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU - Fuentes Fidedignas","og_description":"Pfizer afirm\u00f3 que complet\u00f3 la presentaci\u00f3n de su solicitud de autorizaci\u00f3n de uso de emergencia del f\u00e1rmaco, Paxlovid, ante la FDA. Ciudad de M\u00e9xico.- Pfizer Inc dijo este martes que est\u00e1 solicitando la autorizaci\u00f3n en Estados Unidos para su p\u00edldora antiviral experimental contra el Covid-19, que redujo en un 89% la posibilidad de hospitalizaci\u00f3n o [&hellip;]","og_url":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/","og_site_name":"Fuentes Fidedignas","article_publisher":"https:\/\/www.facebook.com\/Fuentes-Fidedignas-368234489921644","article_published_time":"2021-11-16T21:24:41+00:00","og_image":[{"width":640,"height":360,"url":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/11\/PFIZER_001.jpg","type":"image\/jpeg"}],"author":"Reuters","twitter_card":"summary_large_image","twitter_creator":"@fidedignas","twitter_site":"@fidedignas","twitter_misc":{"Escrito por":"Reuters","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#article","isPartOf":{"@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/"},"author":{"name":"Reuters","@id":"https:\/\/fuentesfidedignas.com.mx\/#\/schema\/person\/699c239076aac7aa88ecc3c15c72710f"},"headline":"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU","datePublished":"2021-11-16T21:24:41+00:00","mainEntityOfPage":{"@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/"},"wordCount":432,"commentCount":0,"publisher":{"@id":"https:\/\/fuentesfidedignas.com.mx\/#organization"},"image":{"@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#primaryimage"},"thumbnailUrl":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/11\/PFIZER_001.jpg","keywords":["Coronavirus","Covid-19","SARS-CoV-2","Vacuna anticovid"],"articleSection":["NOTICIAS NACIONALES"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/","url":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/","name":"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU - Fuentes Fidedignas","isPartOf":{"@id":"https:\/\/fuentesfidedignas.com.mx\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#primaryimage"},"image":{"@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#primaryimage"},"thumbnailUrl":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/11\/PFIZER_001.jpg","datePublished":"2021-11-16T21:24:41+00:00","breadcrumb":{"@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#primaryimage","url":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/11\/PFIZER_001.jpg","contentUrl":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/11\/PFIZER_001.jpg","width":640,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/fuentesfidedignas.com.mx\/index.php\/2021\/11\/16\/pfizer-solicita-autorizacion-para-su-pildora-contra-covid-19-en-eu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/fuentesfidedignas.com.mx\/"},{"@type":"ListItem","position":2,"name":"Pfizer solicita autorizaci\u00f3n para su p\u00edldora contra Covid-19 en EU"}]},{"@type":"WebSite","@id":"https:\/\/fuentesfidedignas.com.mx\/#website","url":"https:\/\/fuentesfidedignas.com.mx\/","name":"Fuentes Fidedignas","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/fuentesfidedignas.com.mx\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fuentesfidedignas.com.mx\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fuentesfidedignas.com.mx\/#organization","name":"Fuentes Fidedignas","url":"https:\/\/fuentesfidedignas.com.mx\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fuentesfidedignas.com.mx\/#\/schema\/logo\/image\/","url":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/04\/logo-retina.png","contentUrl":"https:\/\/fuentesfidedignas.com.mx\/wp-content\/uploads\/2021\/04\/logo-retina.png","width":280,"height":51,"caption":"Fuentes Fidedignas"},"image":{"@id":"https:\/\/fuentesfidedignas.com.mx\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Fuentes-Fidedignas-368234489921644","https:\/\/x.com\/fidedignas"]},{"@type":"Person","@id":"https:\/\/fuentesfidedignas.com.mx\/#\/schema\/person\/699c239076aac7aa88ecc3c15c72710f","name":"Reuters","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/06c46a9bb47e91c2e7c5aa85ad0855c43a11fd5a7b8dd6ec0e8fe8e471140a59?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/06c46a9bb47e91c2e7c5aa85ad0855c43a11fd5a7b8dd6ec0e8fe8e471140a59?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/06c46a9bb47e91c2e7c5aa85ad0855c43a11fd5a7b8dd6ec0e8fe8e471140a59?s=96&d=mm&r=g","caption":"Reuters"},"url":"https:\/\/fuentesfidedignas.com.mx\/index.php\/author\/reuters\/"}]}},"_links":{"self":[{"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/posts\/17606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/comments?post=17606"}],"version-history":[{"count":1,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/posts\/17606\/revisions"}],"predecessor-version":[{"id":17608,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/posts\/17606\/revisions\/17608"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/media\/17607"}],"wp:attachment":[{"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/media?parent=17606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/categories?post=17606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fuentesfidedignas.com.mx\/index.php\/wp-json\/wp\/v2\/tags?post=17606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}